Will TherapeuticsMD's Yuvvexy Pass The FDA Muster?
May 07, 2017 at 14:29 PM EDT
TherapeuticsMD Inc (NYSE: TXMD) shares were down 44.4 percent in 2016. By virtue of an advance seen since late February to early ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.